Loading...
Loading...
TECH| Name | Value |
|---|---|
| Revenues | 306.1M |
| Cost of Revenue | 101.2M |
| Gross Profit | 204.9M |
| Operating Expense | 125.9M |
| Operating I/L | 45.8M |
| Other Income/Expense | -4.2M |
| Interest Income | 0.9M |
| Pretax | 41.7M |
| Income Tax Expense | 1.1M |
| Net Income/Loss | 40.6M |
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for research and clinical diagnostic markets globally. The company operates through two segments: Protein Sciences, which offers biological reagents, proteomic analytical tools, and immunoassays; and Diagnostics and Genomics, which develops and manufactures diagnostic products, including controls, calibrators, and assays for regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays, and genetic and oncology kits for research and clinical applications.
